Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
Immediate priority: Patient safety and regulatory compliance. The signal for liver failure (serious, life-threatening adverse event) triggers obligations under FDA post-marketing requirements (21 CFR 314.80/600.80 for expedited reporting of serious unexpected events, typically within 15 days of awareness for…Read the full answer